31
A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
Condition(s):Opioid Use DisorderLast Updated:June 16, 2021Completed
Buprenorphine, Naloxone Drug Combination as an Intervention: 194 Clinical Trials, Page 4 of 20
Hide Studies Not Open or Pending
32
Buprenorphine Naltrexone-P1 A-Cocaine
Condition(s):Cocaine-related DisordersLast Updated:January 12, 2017Completed
33
Treatment for Opioid Dependent Offenders
Condition(s):Opioid DependenceLast Updated:June 5, 2023Completed
34
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
Condition(s):Opioid UseLast Updated:March 17, 2020Completed
35
Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
Condition(s):Opiate AddictionLast Updated:May 27, 2022Completed
36
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
Condition(s):Opioid Dependence; Opioid Related DisordersLast Updated:February 20, 2018Completed
37
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Condition(s):Opioid-use DisorderLast Updated:August 14, 2023Recruiting
38
Dane County Drug Court Study for Addicted Offenders
Condition(s):Opioid DependenceLast Updated:June 7, 2023Completed
39
Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women
Condition(s):Opioid Use DisorderLast Updated:October 14, 2020Withdrawn
40
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
Condition(s):Opioid Use DisorderLast Updated:January 31, 2017Completed